Cantor Fitzgerald Analysts Raise Earnings Estimates for Mustang Bio, Inc. (NASDAQ:MBIO)

Mustang Bio, Inc. (NASDAQ:MBIO – Get Rating) – Cantor Fitzgerald lifted their FY2022 earnings estimates for Mustang Bio in a research report issued to clients and investors on Monday, August 15th. Cantor Fitzgerald analyst K. Kluska now expects that the company will earn ($0.80) per share for the year, up from their previous forecast of […]

Related Keywords

,Mustang Bio Inc ,Nasdaq ,Sassicaia Capital Advisers ,Cantor Fitzgerald ,Arete Wealth Advisors ,Proshare Advisors ,Envestnet Asset Management Inc ,Cetera Advisor Networks ,Mustang Bio ,Get Rating ,Capital Advisers ,Wealth Advisors ,Share Advisors ,Asset Management ,Mustang Bio Daily ,Nasdaq Mbio ,Yambio ,Medical ,Earnings Estimates ,